Sponsor Pipeline

Kura Oncology, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
5
Recruiting
1
Phase 3
9
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-28 NCT07007312
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With…		 Trial sites expanded: 82 -> 106 locations
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07007312 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With… Acute Myeloid Leukemia (AML) Recruiting
Phase 1/2
NCT04067336 First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Advanced Malignant Neoplasm Active, Not Recruiting
Phase 1
NCT06655246 A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced… Gastrointestinal Stromal Tumor (GIST) Recruiting
NCT05735184 A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With… Acute Myeloid Leukemia Recruiting
NCT06001788 Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory… AML Recruiting
NCT06026410 KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors Solid Tumors With HRAS Alterations Recruiting
Disease Areas
Leukemia (4) Acute Myeloid Leukemia (AML) (4) Acute Lymphoblastic Leukemia (ALL) (1) Sarcoma (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Colorectal Cancer (1) Pancreatic Cancer (1) Kidney Cancer (1)
Get alerts when Kura Oncology, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free